JP2005325108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005325108A5 JP2005325108A5 JP2005119011A JP2005119011A JP2005325108A5 JP 2005325108 A5 JP2005325108 A5 JP 2005325108A5 JP 2005119011 A JP2005119011 A JP 2005119011A JP 2005119011 A JP2005119011 A JP 2005119011A JP 2005325108 A5 JP2005325108 A5 JP 2005325108A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- mmhg
- decrease
- rats
- threshold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000000114 Pain Threshold Diseases 0.000 description 6
- 230000037040 pain threshold Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000026416 response to pain Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005119011A JP4892857B2 (ja) | 2004-04-15 | 2005-04-15 | 更年期症の予防又は改善剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004120864 | 2004-04-15 | ||
| JP2004120864 | 2004-04-15 | ||
| JP2005119011A JP4892857B2 (ja) | 2004-04-15 | 2005-04-15 | 更年期症の予防又は改善剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005325108A JP2005325108A (ja) | 2005-11-24 |
| JP2005325108A5 true JP2005325108A5 (https=) | 2008-04-17 |
| JP4892857B2 JP4892857B2 (ja) | 2012-03-07 |
Family
ID=35471741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005119011A Expired - Fee Related JP4892857B2 (ja) | 2004-04-15 | 2005-04-15 | 更年期症の予防又は改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4892857B2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014091700A (ja) * | 2012-11-02 | 2014-05-19 | Kao Corp | Ｇｌｐ−１分泌促進剤 |
| JP2022071835A (ja) * | 2020-10-28 | 2022-05-16 | 住友化学株式会社 | 月経随伴症状の予防、改善又は緩和のための組成物 |
| JP7564717B2 (ja) * | 2021-01-25 | 2024-10-09 | アサヒグループホールディングス株式会社 | 女性更年期症状の改善剤 |
| CN118765201A (zh) * | 2022-03-01 | 2024-10-11 | 朝日集团控股株式会社 | 女性更年期症状的改善剂 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4589483B2 (ja) * | 2000-05-12 | 2010-12-01 | 花王株式会社 | ニキビ予防治療剤 |
-
2005
- 2005-04-15 JP JP2005119011A patent/JP4892857B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524958A5 (https=) | ||
| JP2008523153A5 (https=) | ||
| WO2007120509A3 (en) | Virucidal/germicidal mask | |
| EP2638905A3 (en) | Biofilm treatment | |
| JP2007508326A5 (https=) | ||
| WO2007127333A3 (en) | Compositions for the treatment and prevention of eyelid swelling | |
| WO2009061431A3 (en) | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor | |
| WO2010091827A3 (de) | Kosmetische zubereitung zur hautpflege | |
| JP2005325108A5 (https=) | ||
| WO2004110392A3 (en) | Compositions and methods for treating coronavirus infection and sars | |
| JP2016538306A5 (https=) | ||
| JP2012528856A5 (https=) | ||
| WO2005041878A3 (en) | Compositions and methods for increasing hdl and hdl-2b levels | |
| WO2004110466A3 (en) | Pediocin-producing pediococci | |
| JP2017525738A5 (https=) | ||
| WO2006076097A3 (en) | Stable non-crystalline formulation comprising losartan | |
| WO2007047837A3 (en) | (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders | |
| WO2008037486A3 (en) | Suspension concentrates for improving root uptake of agrochemically active compounds | |
| WO2006048261A3 (en) | Oral solid dosage forms containing a low dose of estradiol | |
| WO2009068602A3 (en) | Oral care compositions comprising casein, ovalbumin, whey or soy protein | |
| JP2006504741A5 (https=) | ||
| WO2005105135A8 (en) | Il-6 for therapy or prevention of chemotherapy-induced neuropathy | |
| EA200802262A1 (ru) | Назальные и буккальные композиции для борьбы с храпом | |
| WO2008015535A3 (en) | Composition with improved antioxidant and antiglycating activity | |
| JP2002322086A5 (https=) |